Clinical Trial Update: Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating cetuximab re-challenge for colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer, Liver Metastases | Phase 3 | Status: UNKNOWN